// App-Quantinova.ai

: TYPE II KOUNIS SYNDROME IN A PATIENT WITH ANAPHYLAXIS TO DULAGLUTIDE

Researchers

Presenter

  • Varun Kohli

Principal Investigators

  • Yazan Saba

  • Sravanthi Sonti

  • Rehan Kahloon

Medical Centers

  • University of Tennessee, Chattanooga

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

  • Genetic Disorder

  • Pulmonary/Respiratory Diseases

  • Autoimmune (AI)

  • Endocrine/metabolic Diseases (ME)

Disease

  • Type 2 diabetes mellitus

  • Acute Coronary Syndromes

  • Vasodilation dysfunction

  • Dyspnea

  • Multi-vessel disease

  • Diabetes

  • Cardiogenic shock

  • Cardiac arrest

  • Hypertension

  • Anaphylaxis

  • Angina

  • Venous thrombosis

  • Obesity

  • Acrocallosal syndrome

Biomarkers

  • N/A

Drug/Treatment

  • Adrenaclick

  • Diphenhydramine

  • Derma-Pax lotion

  • Epinephrine

  • Dulaglutide

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved